The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Community Health Systems Inc

NYSE: CYH
Last

(U.S.) $18.60

Today's change-1.75 -8.60%
Updated February 8 4:01 PM EST. Delayed by at least 15 minutes.
 

Community Health Systems Inc

NYSE: CYH
Last

(U.S.) $18.60

Today's change-1.75 -8.60%
Updated February 8 4:01 PM EST. Delayed by at least 15 minutes.

Community Health Systems Inc down (U.S.)$1.75

Community Health Systems Inc closed sharply lower Monday, dropping (U.S.)$1.75 or 8.60% to (U.S.)$18.60. Over the last five days, shares have lost 13.69% and are down 29.89% for the last year to date. This security has underperformed the S&P 500 by 50.88% during the last year.

Key company metrics

  • Open(U.S.) $19.71
  • Previous close(U.S.) $20.35
  • High(U.S.) $19.82
  • Low(U.S.) $18.25
  • Bid / Ask(U.S.) $18.60 / (U.S.) $18.65
  • YTD % change-29.89%
  • Volume5,432,703
  • Average volume (10-day)2,934,874
  • Average volume (1-month)3,455,716
  • Average volume (3-month)3,232,371
  • 52-week range(U.S.) $17.65 to (U.S.) $65.00
  • Beta1.12
  • Trailing P/E5.37×
  • P/E 1 year forward5.83×
  • Forward PEG0.84×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.46
Updated February 8 4:01 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+2.57%

Based on its net profit margin of 2.57%, Community Health Systems Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.79%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue4,8464,8824,9114,880
Total other revenue--------
Total revenue4,8464,8824,9114,880
Gross profit4,0844,1324,1494,122
Total cost of revenue762750762758
Total operating expense4,4954,4504,5204,416
Selling / general / administrative2,3702,3453,4723,375
Research & development--------
Depreciation / amortization288291296289
Interest expense (income), net operating--------
Unusual expense (income)091641
Other operating expenses, total1,0751,055-26-47
Operating income351432391464
Interest income (expense), net non-operating-242-239----
Gain (loss) on sale of assets--------
Other--------
Income before tax121214168233
Income after tax83140112167
Income tax, total38745666
Net income5211179100
Total adjustments to net income--------
Net income before extra. items6011792131
Minority interest-23-23-20-36
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items6011792131
Inc. avail. to common incl. extra. items5211179100
Diluted net income5211179100
Dilution adjustment0----0
Diluted weighted average shares116116115115
Diluted EPS excluding extraordinary itemsvalue per share0.521.010.801.14
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.521.060.891.40